A possible role for Epstein-Barr virus in the pathogenesis of pleural effusion

European Respiratory Journal

Volumn 26, Issue 4, 2005, Pages 662-666

  Thijsen, S F T ^a   Luderer, R ^a   van Gorp, J M H ^a   Oudejans, S J G ^a   Bossink, A W J ^a  

^a DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

Epstein Barr virus; Pleural effusion

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; VIRUS DNA;

ADULT; AGED; ANAMNESIS; ARTICLE; BIOCHEMISTRY; CELL COUNT; CONTROLLED STUDY; COUGHING; CYTOLOGY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DNA ISOLATION; EMPYEMA; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IN SITU HYBRIDIZATION; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MICROBIOLOGICAL PARAMETERS; MORTALITY; PATHOGENESIS; PLEURA EFFUSION; PLEURA FLUID; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; SERUM; VIRUS GENOME; VIRUS INFECTION; VIRUS REACTIVATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PLEURAL EFFUSION; PREVALENCE; PROSPECTIVE STUDIES;

EID: 26844444249     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00131204     Document Type: Article

References (26)

1. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343: 481-492.
2. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350: 1328-1337.
3. van Esser JW, van der HB, Meijer E, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 2001; 98: 972-978.
4. Baldanti F, Grossi P, Furione M, et al. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol 2000; 38: 613-619.
5. Ling PD, Vilchez RA, Keitel WA, et al. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 2003; 37: 1244-1249.
6. Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001; 98: 280-286.
7. van Kooy B, Thijsen SFT, Meijer E, et al. Sequence analysis of EBV DNA isolated from mouth washings and PBMC's of healthy individuals and blood of EBV-LPD patients. J Clin Virol 2003; 28: 85-92.
8. Collins TR, Sahn SA. Thoracocentesis. Clinical value, complications, technical problems, and patient experience. Chest 1987; 91: 817-822.
9. Offit PA, Fleisher GR, Koven NL, Plotkin SA. Severe Epstein-Barr virus pulmonary involvement. J Adolesc Health Care 1981; 2: 121-125.
10. Alpert G, Fleisher GR. Complications of infection with Epstein-Barr virus during childhood: a study of children admitted to the hospital. Pediatr Infect Dis 1984; 3: 304-307.
11. Chen J, Konstantinopoulos PA, Satyal S, Telonis J, Blair DC. Just another simple case of infectious mononucleosis? Lancet 2003; 361: 1182.
12. Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators. Chest 1997; 111: 970-980.
13. Niesters HG, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus AD. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000; 38: 712-715.
14. Niesters HG. Clinical virology in real time. J Clin Virol 2002; 25: Suppl. 3, 3-12.
15. Berger C, Day P, Meier G, Zingg W, Bossart W, Nadal D. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol 2001; 64: 505-512.
16. Decker LL, Klaman LD, Thorley-Lawson DA. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J Virol 1996; 70: 3286-3289.
17. Wagner HJ, Bein G, Bitsch A, Kirchner H. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J Clin Microbiol 1992; 30: 2826-2829.
18. Miyashita EM, Yang B, Lam KM, Crawford DH, Thorley-Lawson DA. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 1995; 80: 593-601.
19. Kimura H, Nishikawa K, Hoshino Y, Sofue A, Nishiyama Y, Morishima T. Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection. Med Microbiol Immunol (Berl) 2000; 188: 197-202.
20. Mattison LE, Coppage L, Alderman DF, Herlong JO, Sahn SA. Pleural effusions in the medical ICU: prevalence, causes, and clinical implications. Chest 1997; 111: 1018-1023.
21. Yang PC, Luh KT, Chang DB, Wu HD, Yu CJ, Kuo SH. Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. Am J Roentgenol 1992; 159: 29-33.
22. Daibata M, Taguchi T, Nemoto Y, et al. Epstein-Barr virus (EBV)-positive pyothorax-associated lymphoma (PAL): chromosomal integration of EBV in a novel CD2-positive PAL B-cell line. Br J Haematol 2002; 117: 546-557.
23. Nakatsuka S, Yao M, Hoshida Y, Yamamoto S, Iuchi K, Aozasa K. Pyothorax-associated lymphoma: a review of 106 cases. J Clin Oncol 2002; 20: 4255-4260.
24. Hengge UR, Ruzicka T, Tyring SK, et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2002; 2: 344-352.
25. Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 2003; 67: 175-212.
26. Jenner RG, Maillard K, Cattini N, et al. Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci USA 2003; 100: 10399-10404.